Piper Sandler keeps Hold on Medtronic stock at USD 85.00

Published on 10/26/2026 at 16:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Analysts average USD 104.62 across 30 ratings. Medtronic stock costs EUR 84.70 on October 26, 2026, down 1.19 percent versus Xetra close.

Piper Sandler target decision

Piper Sandler reiterated a Hold rating and set a USD 85.00 target on October 22, 2026.
Thirty analysts had an average target of USD 104.62 on October 26, 2026.
Medtronic stock costs EUR 84.70 at Lang & Schwarz on October 26, 2026 at 4:10 p.m. CEST, 1.19 percent below the Xetra close of October 23, 2026.
Medtronic traded at a price-to-earnings ratio of 23.34 and a 3.00 percent dividend yield.

Medtronic plc, IE00BTN1Y115, Illustration mit AI erstellt.

On October 22, 2026, Piper Sandler analyst Matthew O'Brien reiterated a Hold rating on Medtronic and set a USD 85.00 price target, according to Markets Insider. Medtronic stock was trading at EUR 84.70 at Lang & Schwarz on October 26, 2026 at 4:10 p.m. CEST, down 1.19 percent versus the Xetra close of October 23, 2026 at EUR 85.72.

Analyst targets split the view

Piper Sandler's USD 85.00 target stood 10.18 percent below Medtronic's USD 94.63 NYSE price at 11:21 a.m. ET on October 26, 2026. The contrast is material because a broader analyst view remained higher.

MarketScreener listed 30 analysts with a mean target of USD 104.62 and a Buy consensus on October 26, 2026. That target was 10.56 percent above the NYSE price, while the Piper Sandler target was 10.18 percent below it.

Stock sits 20.35 percent below high

Medtronic's NYSE price was USD 94.63 on October 26, 2026, while its 52-week range ran from USD 73.31 to USD 106.33. The stock stood 10.99 percent below its 52-week high, and the euro quote was 20.35 percent below its comparable high after the currency perspective is kept separate. Medtronic's market capitalization was USD 121.0 billion.

Valuation and dividend remain visible

Medtronic traded at a price-to-earnings ratio of 23.34 and carried a 3.00 percent dividend yield on October 26, 2026. Its NYSE listing and MDT ticker were identified in Medtronic's official investor materials, which describe the company as a medical technology business serving cardiovascular, surgical, neuroscience and diabetes markets.

Comparison with peers

Medtronic plc: down 0.82 percent, P/E 23.34, market capitalization USD 121.0 billion.

Abbott Laboratories (NYSE, USD): up 1.13 percent, P/E 38.80, market capitalization USD 181.5 billion.

Boston Scientific (NYSE, USD): down 0.55 percent, P/E 18.48, market capitalization USD 65.8 billion.

The stock's immediate position

The current euro quote is below the October 23 Xetra close, while the analyst range spans USD 85.00 to USD 104.62 against a USD 94.63 NYSE price. That spread leaves the rating and target gap as the clearest market measures around Medtronic today. The further course of trading is shown by the continuously updated real-time quote of Medtronic stock.